Ron Blankstein, M.D., director of cardiac computed tomography, Brigham and Women's Hospital, and associate professor of medicine and radiology, Harvard Medical School, offers an overview of the recent trends in cardiac CT and some of the new highlights at the Society of Cardiovascular Computed Tomography (SCCT) 2019 meeting. He said key topics included integration of artificial intelligence into CT systems, the integration of CT calcium scoring into the 2018 American Heart Association (AHA) cholesterol management guidelines, structural heart assessments for transcatheter valve and left atrial appendage (LAA) occlusion, and partner sessions with TCT and HRS that explain the roll of CT in interventional cardiology and electrophysiology.
Federico Asch, M.D., FASE, director of cardiac imaging research and director of the cardiovascular imaging lab, MedStar Health Research Institute, Washington, D.C., explains the importance of the COAPT Trial and the cardiac ultrasound findings from the study. It was presented as a late-breaking study at the American College of Cardiology (ACC) 2019 meeting and the sub-study was discussed in several sessions at the 2019 American Society of Echocardiography (ASE) conference.
The trial showed the Abbott MitraClip can be used to help large numbers of patients with heart failure who experience increasing levels of mitral valve regurgitation due to the enlargement of their hearts.
Read more about the COAPT Trial
VIDEO: MitraClip to Treat Heart Failure - Results of the COAPT Trial — Interview with William Abraham M.D.
VIDEO: Impact of the COAPT Trial on Heart Failure Patients With Functional Mitral Regurgitation — Interview with Andreas Brieke, M.D.
FDA Approves MitraClip for Use in Heart Failure Patients With Functional Mitral Regurgitation
Recent Videos View all 469 items
CT Angiography (CTA) | July 19, 2019
Quynh Truong, M.D., MPH, associate professor of radiology and medicine at Weill Cornell and director of cardiac CT, NewYork Presbyterian Hospital, offers 10 tips to help improve image quality for cardiovascular computed tomography (CTA) exams. She spoke on this topic at the Society of Cardiovascular Computed Tomography (SCCT) 2019 meeting.
Her discussion includes:
1. Practice the breath hold
2. Give nitrate to vasodilate
3. Slow the heart rate
4. Acquire multiple phases with padding
5. Include systolic imaging for irregular heart beats
6. Consider cauo-cranial imaging to avoid contrast enhancement issues
7. Use a high contrast injection rate
8. Right ventricular opacification for function
9. Use a hard kernel
10. Know your post-processing software
VIDEO: Tips and Tricks to Aid Cardiac CT Technologist Workflow
Cardiovascular Ultrasound | July 10, 2019
This is an example of a cardiac echocardiography exam performed using an iPhone and the Butterfly IQ ultrasound transducer and app. The company is exhibiting at the American Society Of Echocardiography (ASE) 2019 meeting. This is the first “ultrasound system on a chip.” The Butterfly IQ ultrasound system consists of a transducer that connects to an iPhone or iPad to record ultrasound exams. The system has 18 different applications for specialized images, including cardiac imaging, vascular, lung, abdominal and others. The apps allow for quantification and offers many of the features of larger cart-based systems. The company is working on incorporating artificial intelligence technologies to automate some processes, such as auto ejection fractions.
This technology was picked as one of the big ultrasound advances in the VIDEO: 4 Recent Advances in Echocardiography Technology and in the VIDEO: Editor's Choice of the Most Innovative New Technology at RSNA 2018.
Artificial Intelligence | July 02, 2019
Judy Hung, M.D., director of echocardiography, Division of Cardiology, Massachusetts General Hospital, Boston, discusses how her center is partnering to develop artificial intelligence (AI) applications to help improve image quality and speed workflow in cardiac ultrasound. She spoke to DAIC at the 2019 American Society of Echocardiography (ASE).
Cardiovascular Ultrasound | July 01, 2019
Federico Asch, M.D., FASE, director of cardiac imaging research and director of the cardiovascular imaging lab, MedStar Health Research Institute, Washington, D.C., spoke about the cardiovascular impact of chagas disease and the symptoms that should be considered for patients who are from, or visited, South or Central America. He spoke on the topic at the 2019 American Society Of Echocardiography (ASE) meeting.
Chagas, also called trypanosomiasis, is a tropical parasitic disease caused by the protist Trypanosoma cruzi. It is spread through the bite of the triatominae insect, which is also known as the "kissing bug." Link to the Center for Disease Control (CDC) page on Chagas.
Asch served as the co-chair of the group that created the guidelines to image Chagas disease.
Find more news and video from ASE 2019
Cardiovascular Ultrasound | July 01, 2019
Partho Sengupta, M.D., MBBS, chief of cardiology, West Virginia Heart and Vascular Institute, explains how wearable, smartphone-based apps and medical devices, and artificial intelligence (AI) might be used to cost-effectively triage larger numbers of patients in rural areas and in the developing world for serious diseases. He spoke at the 2019 American Society Of Echocardiography (ASE) meeting.
Sengupta is involved with a pilot program using the Butterfly app and transducer to turn a smartphone into an inexpensive ultrasound system. He said the idea is to have novice ultrasound users screen more patients with these types of devices and the exams either being sent to a remote hospital for reading. He said AI algorithms also could be used to help flag any exams that show abnormalities, which would greatly speed reads and getting these patients treatment.
Watch the related VIDEO: How Smartphones May Revolutionize Healthcare in the Developing World — Interview with Jacques Kpodonu, M.D.,
Find more news and video from ASE 2019
Contrast Media | June 28, 2019
Sharon Mulvagh, M.D., FASE, FACC, FRCPC, professor of medicine, division of cardiology, Dalhousie University, Halifax, Nova Scotia, Canada, and professor emeritus, Mayo Clinic, explains the latest updates to guidelines for the use of cardiovascular ultrasound enhancing imaging agents. She spoke to DAIC at the 2019 American Society of Echocardiography (ASE) meeting.
The changes include a new term for contrast so the agents are not confused with safety issues regarding gadolinium, iodine-based contrast or radioactive nuclear radiotracers. She gives an overview of the 2018 guidelines that are based on a large level of clinical study evidence. Previously, the ASE issued a statement rather than a guideline, because the more clinical evidence was needed for more a more conclusive set of guidelines.
Read the full guidelines: Clinical Applications of Ultrasonic Enhancing Agents in Echocardiography: 2018 American Society of Echocardiography Guidelines Update.
Find more news and videos from ASE 2019.
Artificial Intelligence | June 28, 2019
This is a quick example of how artificial intelligence (AI) is being integrated on the back end of cardiac ultrasound systems to help automate and speed workflows. This video segment is from the expo floor of the 2019 American Society of Echocardiography (ASE) meeting. It shows AI-based AFI automation features incorporated into the GE Vivid E95 echo system.
Read a blog about how AI will help advance cardiac ultrasound imaging, Combatting the No. 1 Cause of Death With the Help of Artificial Intelligence and Advanced Technology.
Sponsored Videos View all 44 items
Information Technology | April 17, 2019
With Intellispace Enterprise Edition as the foundation, Philips Healthcare is connecting facilities and service areas within enterprises, while developing standards-based interoperability that preserves customers' investments and best of breed systems.
Hemodynamic Support Devices | March 06, 2019
Perwaiz Meraj, M.D., FACC, FSCAI, director of interventional cardiology, assistant professor, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Northwell Health System discusses the importance of hemodynamic support to safely perform a percutaneous coronary intervention (PCI) with prior coronary artery bypass graft (CABG) surgery and comorbidities. Learn more at ProtectedPCI.com/DAIC.
In this video, Meraj discuss a complex coronary intervention of a 77-year-old woman with stage 4 CKD, prior CABG, hypertension, hyperlipidemia, diabetes, who presented with angina and NSTEMI with an ejection fraction of 40 percent. The team at Northwell consulted with cardiac surgeons and the heart team, and determined that this patient was too high risk for another bypass surgery. Read more on this case.
Related Impella Video Content:
VIDEO: Analysis of Outcomes for 15,259 U.S. Patients with AMICS Supported with the Impella Device — Interview with William O'Neill, M.D.
VIDEO: The Door-to-Unloading (DTU) STEMI Safety and Feasibility Trial — Interview with Navin Kapur, M.D.
VIDEO: Cardiogenic Shock Case with Impella CP Support — Case study with Michael Amponsah, M.D.,
Heart Failure | February 13, 2019
William O'Neill, M.D., highlights best practice protocols based on Impella Quality database and real-world evidence showing improved outcomes in cardiogenic shock. Learn more at ProtectedPCI.com/DAIC
Related Impella Video Content:
VIDEO: Complex PCI Involving Prior CABG and Comorbidities — Interview with Perwaiz Meraj, M.D.
VIDEO: The Door-to-Unloading (DTU) STEMI Safety and Feasibility Trial — Interview with Navin Kapur, M.D.
VIDEO: Cardiogenic Shock Case with Impella CP Support — Case study with Michael Amponsah, M.D.,
January 10, 2019
Mark Anderson, M.D., FACS, vice chair of cardiac surgery services and cardiothoracic surgeon at Hackensack University Medical Group, outlines a multi-disciplinary heart team approach in treament decision-making for patients in cardiogenic shock. Learn more at ProtectedPCI.com/DAIC.
Anderson discusses improving outcomes for patients in cardiogenic shock through the early use of mechanical circulatory support and the development of a shock protocol with the heart team. He outlines Hackensack University Medical Center’s multi-disciplinary, heart team approach in treatment decision-making for patients in cardiogenic shock. The team includes cardiac surgeons, interventional cardiologists, heart failure specialists and intensivists.
Hemodynamic Support Devices | December 13, 2018
Michael Amponsah, M.D., FACC, an interventional cardiologist at Mohawk Valley Health System, shares a case of Impella CP for a non-ischemic cardiomyopathy patient who presented in cardiogenic shock. Learn more at ProtectedPCI.com/DAIC.
The patient, a 51-year-old male, was diagnosed with NYHA Class III non-ischemic systolic heart failure with an ejection fraction of 20 percent and an ICD. He presented to the emergency department with ICD shocks and his hemodynamics declined over a 12 hour period and blood work showed a 20 percent decline in kidney function. Amponsah placed a right heart cath and performed an echocardiogram showing LV dysfunction. The team decided to place an Impella CP in the cath lab to support the patient’s heart. This was effective in unloading the LV and organ perfusion. This also provided the team with time to transfer the patient to another facility.
Related Impella Video Content:
VIDEO: Complex PCI Involving Prior CABG and Comorbidities — Interview with Perwaiz Meraj, M.D.
VIDEO: Analysis of Outcomes for 15,259 U.S. Patients with AMICS Supported with the Impella Device — Interview with William O'Neill, M.D.
VIDEO: The Door-to-Unloading (DTU) STEMI Safety and Feasibility Trial — Interview with Navin Kapur, M.D.
Cath Lab | November 15, 2018
Navin Kapur, M.D., discusses the results of the FDA STEMI Door-to-Unloading (DTU) safety and feasibility randomized controlled trial, presented as a late-breaking study at the 2018 American Heart Association meeting. Learn more at ProtectedPCI.com/DAIC.
Related Impella Video Content:
VIDEO: Complex PCI Involving Prior CABG and Comorbidities — Interview with Perwaiz Meraj, M.D.
VIDEO: Analysis of Outcomes for 15,259 U.S. Patients with AMICS Supported with the Impella Device — Interview with William O'Neill, M.D.
VIDEO: Cardiogenic Shock Case with Impella CP Support — Case study with Michael Amponsah, M.D.,
Cath Lab | November 07, 2018
In 2009, the GuideLiner Catheter revolutionized the concept of guide extension, creating new possibilities in interventional cardiology. Now in its third generation, the GuideLiner V3 Catheter continues to build on a history of innovation and performance — one that has been demonstrated with more than half a million catheters in cath labs around the world.
Teleflex also offers a family of Turnpike Catheters. These contain a robust multi-layer shaft that provides impressive flexibility, torque and tracking over a 0.014” guidewire in complex coronary and peripheral interventions. The unique five-layer composite shaft provides an ideal combination of flexibility and torque response to help navigate through complex anatomy while the outer polymer layer paired with a 60 cm distal hydrophilic coating facilitates smooth catheter delivery. This portfolio consists of the Turnpike Catheter (standard version), the Turnpike Spiral Catheter, the Turnpike Gold Catheter, and the Turnpike LP Catheter. Each catheter configuration contains a specific design element to address various clinical challenges in complex procedures
This year, Teleflex acquired two well-known PTCA balloon catheters. The Chocolate XD PTCA Balloon Catheter is a specialty angioplasty balloon, used in the pre-dilatation and treatment of coronary lesions. The balloon’s proprietary nitinol constraining structure creates “pillows” and “grooves” that are designed to provide controlled dilatation while minimizing vessel wall trauma.
The Glider PTCA Balloon Catheter is a semi-compliant balloon with a skived tip and low entry profile. The tip design, coupled with hydrophilic coating and an innovative, torqueable shaft, allows for precise tip orientation for use in crossing complex lesions and stent struts.
For more information: www.teleflex.com
Cath Lab | October 24, 2018
Michael Flaherty, M.D., discusses a study published in Circulation Research which finds that use of hemodynamic support with the Impella 2.5 heart pump during high-risk PCI can reduce the risk of AKI even when those patients had pre-existing kidney disease and a low ejection fraction. For more information: http://bit.ly/2Pfaqxh
Related Impella Video Content:
VIDEO: Analysis of Outcomes for 15,259 U.S. Patients with AMICS Supported with the Impella Device — Interview with William O'Neill, M.D.
VIDEO: The Door-to-Unloading (DTU) STEMI Safety and Feasibility Trial — Interview with Navin Kapur, M.D.
VIDEO: Cardiogenic Shock Case with Impella CP Support — Case study with Michael Amponsah, M.D.
Conference Videos View all 354 items
SCCT | July 19, 2019
Ron Blankstein, M.D., director of cardiac computed tomography, Brigham and Women's Hospital, and associate professor of medicine and radiology, Harvard Medical School, offers an overview of the recent trends in cardiac CT and some of the new highlights at the Society of Cardiovascular Computed Tomography (SCCT) 2019 meeting. He said key topics included integration of artificial intelligence into CT systems, the integration of CT calcium scoring into the 2018 American Heart Association (AHA) cholesterol management guidelines, structural heart assessments for transcatheter valve and left atrial appendage (LAA) occlusion, and partner sessions with TCT and HRS that explain the roll of CT in interventional cardiology and electrophysiology.
CT Angiography (CTA) | July 19, 2019
Quynh Truong, M.D., MPH, associate professor of radiology and medicine at Weill Cornell and director of cardiac CT, NewYork Presbyterian Hospital, offers 10 tips to help improve image quality for cardiovascular computed tomography (CTA) exams. She spoke on this topic at the Society of Cardiovascular Computed Tomography (SCCT) 2019 meeting.
Her discussion includes:
1. Practice the breath hold
2. Give nitrate to vasodilate
3. Slow the heart rate
4. Acquire multiple phases with padding
5. Include systolic imaging for irregular heart beats
6. Consider cauo-cranial imaging to avoid contrast enhancement issues
7. Use a high contrast injection rate
8. Right ventricular opacification for function
9. Use a hard kernel
10. Know your post-processing software
VIDEO: Tips and Tricks to Aid Cardiac CT Technologist Workflow
Cardiovascular Ultrasound | July 10, 2019
This is an example of a cardiac echocardiography exam performed using an iPhone and the Butterfly IQ ultrasound transducer and app. The company is exhibiting at the American Society Of Echocardiography (ASE) 2019 meeting. This is the first “ultrasound system on a chip.” The Butterfly IQ ultrasound system consists of a transducer that connects to an iPhone or iPad to record ultrasound exams. The system has 18 different applications for specialized images, including cardiac imaging, vascular, lung, abdominal and others. The apps allow for quantification and offers many of the features of larger cart-based systems. The company is working on incorporating artificial intelligence technologies to automate some processes, such as auto ejection fractions.
This technology was picked as one of the big ultrasound advances in the VIDEO: 4 Recent Advances in Echocardiography Technology and in the VIDEO: Editor's Choice of the Most Innovative New Technology at RSNA 2018.
Artificial Intelligence | July 02, 2019
Judy Hung, M.D., director of echocardiography, Division of Cardiology, Massachusetts General Hospital, Boston, discusses how her center is partnering to develop artificial intelligence (AI) applications to help improve image quality and speed workflow in cardiac ultrasound. She spoke to DAIC at the 2019 American Society of Echocardiography (ASE).
Cardiovascular Ultrasound | July 01, 2019
Federico Asch, M.D., FASE, director of cardiac imaging research and director of the cardiovascular imaging lab, MedStar Health Research Institute, Washington, D.C., spoke about the cardiovascular impact of chagas disease and the symptoms that should be considered for patients who are from, or visited, South or Central America. He spoke on the topic at the 2019 American Society Of Echocardiography (ASE) meeting.
Chagas, also called trypanosomiasis, is a tropical parasitic disease caused by the protist Trypanosoma cruzi. It is spread through the bite of the triatominae insect, which is also known as the "kissing bug." Link to the Center for Disease Control (CDC) page on Chagas.
Asch served as the co-chair of the group that created the guidelines to image Chagas disease.
Find more news and video from ASE 2019
Cardiovascular Ultrasound | July 01, 2019
Partho Sengupta, M.D., MBBS, chief of cardiology, West Virginia Heart and Vascular Institute, explains how wearable, smartphone-based apps and medical devices, and artificial intelligence (AI) might be used to cost-effectively triage larger numbers of patients in rural areas and in the developing world for serious diseases. He spoke at the 2019 American Society Of Echocardiography (ASE) meeting.
Sengupta is involved with a pilot program using the Butterfly app and transducer to turn a smartphone into an inexpensive ultrasound system. He said the idea is to have novice ultrasound users screen more patients with these types of devices and the exams either being sent to a remote hospital for reading. He said AI algorithms also could be used to help flag any exams that show abnormalities, which would greatly speed reads and getting these patients treatment.
Watch the related VIDEO: How Smartphones May Revolutionize Healthcare in the Developing World — Interview with Jacques Kpodonu, M.D.,
Find more news and video from ASE 2019
Contrast Media | June 28, 2019
Sharon Mulvagh, M.D., FASE, FACC, FRCPC, professor of medicine, division of cardiology, Dalhousie University, Halifax, Nova Scotia, Canada, and professor emeritus, Mayo Clinic, explains the latest updates to guidelines for the use of cardiovascular ultrasound enhancing imaging agents. She spoke to DAIC at the 2019 American Society of Echocardiography (ASE) meeting.
The changes include a new term for contrast so the agents are not confused with safety issues regarding gadolinium, iodine-based contrast or radioactive nuclear radiotracers. She gives an overview of the 2018 guidelines that are based on a large level of clinical study evidence. Previously, the ASE issued a statement rather than a guideline, because the more clinical evidence was needed for more a more conclusive set of guidelines.
Read the full guidelines: Clinical Applications of Ultrasonic Enhancing Agents in Echocardiography: 2018 American Society of Echocardiography Guidelines Update.
Find more news and videos from ASE 2019.
Artificial Intelligence | June 28, 2019
This is a quick example of how artificial intelligence (AI) is being integrated on the back end of cardiac ultrasound systems to help automate and speed workflows. This video segment is from the expo floor of the 2019 American Society of Echocardiography (ASE) meeting. It shows AI-based AFI automation features incorporated into the GE Vivid E95 echo system.
Read a blog about how AI will help advance cardiac ultrasound imaging, Combatting the No. 1 Cause of Death With the Help of Artificial Intelligence and Advanced Technology.
Cath Lab View all 217 items
Heart Failure | June 28, 2019
Federico Asch, M.D., FASE, director of cardiac imaging research and director of the cardiovascular imaging lab, MedStar Health Research Institute, Washington, D.C., explains the importance of the COAPT Trial and the cardiac ultrasound findings from the study. It was presented as a late-breaking study at the American College of Cardiology (ACC) 2019 meeting and the sub-study was discussed in several sessions at the 2019 American Society of Echocardiography (ASE) conference.
The trial showed the Abbott MitraClip can be used to help large numbers of patients with heart failure who experience increasing levels of mitral valve regurgitation due to the enlargement of their hearts.
Read more about the COAPT Trial
VIDEO: MitraClip to Treat Heart Failure - Results of the COAPT Trial — Interview with William Abraham M.D.
VIDEO: Impact of the COAPT Trial on Heart Failure Patients With Functional Mitral Regurgitation — Interview with Andreas Brieke, M.D.
FDA Approves MitraClip for Use in Heart Failure Patients With Functional Mitral Regurgitation
Cath Lab | June 26, 2019
Thomas Porter, M.D., FASE, the Theordore F. Hubbard Distinguished Chair of Cardiology and a professor of medicine at the University of Nebraska Medical Center, explains a new study on how cardiac ultrasound imaging combined with bubble contrast was able to break down blood clots and restore blood flow to blocked vessels in STEMI heart attack patients. He gave an update on this new potential therapeutic direction for ultrasound at the 2019 American Society Of Echocardiography (ASE) meeting.
The Brazilian study used this approach in about 100 ST-elevated myocardial infarction (STEMI) patients and was recently published in the Journal of the American College of Cardiology (JACC). Porter said about 50 percent of patients had their ST resolved by the time they made it to the cath lab for percutaneous coronary intervention (PCI). Two more studies in Amsterdam and Pittsburgh are now starting to see if this technique can be used while transporting patients in an ambulance to further improve heart attack outcomes and to reduce infarct size.
Porter also explains recent research that shows ultrasound pulses promote ATP and nitric acid production, which have a lasting beneficial effect on small vessel perfusion in the area treated and down stream for hours after the use of the transducer.
Watch the VIDEO: Therapeutic Applications for Contrast Ultrasound — another interview with Porter.
Cath Lab | May 20, 2019
This is a walk through of the primary structural heart hybrid cath lab at Henry Ford Hospital in Detroit, Mich. It is the hospital's newest lab and is centered around a Philips Azurion angiography system, which is a low dose imaging system that significantly reduces dose exposure compared to previous generation systems. As seen in the video, the lab is also equipped with a vascular access ultrasound system, transesophageal echo (TEE) system, an Abiomed Impella console, a large number of storage cabinets, surgical lighting for cases that convert over to open surgery or for transapical TAVR access, movable radiation shielding and ample space to accommodate surgical equipment and extra staff involved in structural heart procedures. There also is an electrosurgical cutter unit in the lab, which Henry Ford operators use to perform transcaval access TAVR procedures for patients who have anatomical challenges to the femoral access route.
Watch the related VIDEO: Overview of the Henry Ford Hospital Structural Heart Program
Find more Henry Ford videos and news.
Heart Valve Technology | May 20, 2019
A demonstration of how to calculate the neo-left ventricular outflow tract (neo-LVOT) on CT imaging for a transcatheter mitral valve replacement using Circle Imaging's advanced visualization software. The demonstration looks at the use of an Edward's Sapien valve being implanted for a mitral valve-in-valve procedure. The overhang of the Sapien can block the LVOT blood flow, which can be catastrophic for the patient. So, assessment of the neo-LVOT in a simulation of the implant is required prior to the procedure to find the ideal landing zone and assess if the patient's anatomy is compatible with this technique.
Watch the related VIDEO: The Importance of the Neo-LVOT in Transcatheter Mitral Valve Replacement — an interview with Dee Dee Wang, M.D., director of structural heart imaging, Henry Ford Hospital.
This clip was recorded on the expo floor at the 2018 Society of Cardiovascular Computed Tomography (SCCT).
Stroke | May 16, 2019
This is an example of a carotid artery reporting module from Change Healthcare at 2018 Radiological Society of North America (RSNA) annual meeting. It shows how the PACS can bring in ultrasound imaging of the carotid artery and the graphical report can be modified to match the patient anatomy. The text and modifications made to the vessel tree convert into text to help auto-fill fields in the written report to help speed workflow. The vessel tree is similar to cath lab reporting systems that use a similar model of the coronaries that can be modified and helps auto complete the cath report.
Related Content:
VIDEO: What to Look for in PACS Workflow Efficiency
6 Key Health Information Technology Trends at HIMSS 2019
The Building Blocks of Enterprise Imaging
Technology Report: Enterprise Imaging
University of Colorado Hospital | May 09, 2019
Interview with John Carroll, M.D., director of interventional cardiology, Robert Quaife, M.D., director of advanced cardiac imaging, and James Chen, Ph.D., associate professor of medicine and director of the 3-D imaging lab at the Cardiac and Vascular Center at the University of Colorado Hospital. They discuss how the structural heart program was created and how they invested in advanced imaging to grow into one of the most advanced programs in the country. They explain how the program now incorporates transcatheter aortic valve replacement (TAVR), transcatheter mitral valve repair, transcatheter mitral valve replacement (TMVR), left atrial appendage (LAA) occlusion and transcatheter closure of holes in the heart.
The heart team in this video stressed the need for advanced imaging to plan and guide the procedures. They explain how the center developed its own 3-D imaging software and worked with Philips healthcare to commercialize some of the technologies, including the EchoNavigator system used to fuse live angiography with live transesophageal echo (TEE).
Related University of Colorado Hospital Content:
Highlighting Innovation at the University of Colorado Hospital Cardiology Program
VIDEO: Evolution of Transcatheter Mitral Valve Repair at the University of Colorado — Interview with John Carroll, M.D., and Robert Quaife, M.D.
VIDEO: The Role of Advanced Imaging in Structural Heart Interventions — Interview with Robert Quaife, M.D.
VIDEO: Advice For Hospitals Starting a Structural Heart Program — Interview with John Carroll, M.D.
VIDEO: The Evolution of Complex PCI at University of Colorado — Interview with John Messenger, M.D., and Kevin Rogers, M.D.
VIDEO: Developing New Cath Lab Technologies With Real-time Collaboration Between Industry, Doctors
360 View of the TEE Echo Workstation During a MitraClip Procedure
VIDEO: Walk Through of a Hybrid Cath Lab at the University of Colorado Hospital
VIDEO: Cath Lab Walk Through at the University of Colorado Hospital
VIDEO: The Cardiac Surgeon Perspective on Transcatheter Mitral Valve Repair — Interview with Joe Cleveland, M.D.
VIDEO: An Overview of PFO Closure to Treat Cryptogenic Stroke — Interview with Karen Orjuela, M.D.,
Structural Heart | May 06, 2019
John Carroll, M.D., FACC, FSCAI, director of interventional cardiology and co-director of the Cardiac and Vascular Center at the University of Colorado Hospital, offers an overview of the Society of Thoracic Surgeons and American College of Cardiology (STS/ACC) Transcatheter Valve Therapy (TVT) Registry and how it is being used. The data from the registry is being used to accelerate advancement of transcatheter valve repair and replacement technology and facilitate faster regulatory reviews. This included the FDA's adding of a new indication for the use of current TAVR valves for valve-in-valve procedures. The registry also offers comparisons for things like surgical aortic valve replacement (SAVR) vs. transcatheter aortic valve replacement (TAVR) and how procedural volume impacts outcomes.
Additional videos and coverage of the University of Colorado Hospital
Reference:
1. John D. Carroll. STS/ACC TVT Registry: Multiple Benefits For All Stakeholders. JACC Mar 13, 2019.
Cath Lab Navigation Aids | May 01, 2019
Alex Haak, Ph.D., clinical scientist at Philips Health Systems North America, is based at the University of Colorado Hospital, to work directly with physicians in the cath lab to gather immediate feedback and improve next generation fusion imaging technologies used for structural heart interventions. Philips worked with the University of Colorado to develop the EchoNavigator, which fuses 3-D anatomical imaging, live transesophageal echo (TEE) and live fluoroscopy in the cath lab to help guide structural heart procedures. Haak is permanently based at the hospital to help trouble shoot and tweak the new EchoNavigator and other interventional guidance technologies being alpha-tested there prior to final commercialization.
Additional videos and coverage of the University of Colorado Hospital
Cardiac Imaging View all 218 items
SCCT | July 19, 2019
Ron Blankstein, M.D., director of cardiac computed tomography, Brigham and Women's Hospital, and associate professor of medicine and radiology, Harvard Medical School, offers an overview of the recent trends in cardiac CT and some of the new highlights at the Society of Cardiovascular Computed Tomography (SCCT) 2019 meeting. He said key topics included integration of artificial intelligence into CT systems, the integration of CT calcium scoring into the 2018 American Heart Association (AHA) cholesterol management guidelines, structural heart assessments for transcatheter valve and left atrial appendage (LAA) occlusion, and partner sessions with TCT and HRS that explain the roll of CT in interventional cardiology and electrophysiology.
CT Angiography (CTA) | July 19, 2019
Quynh Truong, M.D., MPH, associate professor of radiology and medicine at Weill Cornell and director of cardiac CT, NewYork Presbyterian Hospital, offers 10 tips to help improve image quality for cardiovascular computed tomography (CTA) exams. She spoke on this topic at the Society of Cardiovascular Computed Tomography (SCCT) 2019 meeting.
Her discussion includes:
1. Practice the breath hold
2. Give nitrate to vasodilate
3. Slow the heart rate
4. Acquire multiple phases with padding
5. Include systolic imaging for irregular heart beats
6. Consider cauo-cranial imaging to avoid contrast enhancement issues
7. Use a high contrast injection rate
8. Right ventricular opacification for function
9. Use a hard kernel
10. Know your post-processing software
VIDEO: Tips and Tricks to Aid Cardiac CT Technologist Workflow
Cardiovascular Ultrasound | July 10, 2019
This is an example of a cardiac echocardiography exam performed using an iPhone and the Butterfly IQ ultrasound transducer and app. The company is exhibiting at the American Society Of Echocardiography (ASE) 2019 meeting. This is the first “ultrasound system on a chip.” The Butterfly IQ ultrasound system consists of a transducer that connects to an iPhone or iPad to record ultrasound exams. The system has 18 different applications for specialized images, including cardiac imaging, vascular, lung, abdominal and others. The apps allow for quantification and offers many of the features of larger cart-based systems. The company is working on incorporating artificial intelligence technologies to automate some processes, such as auto ejection fractions.
This technology was picked as one of the big ultrasound advances in the VIDEO: 4 Recent Advances in Echocardiography Technology and in the VIDEO: Editor's Choice of the Most Innovative New Technology at RSNA 2018.
Artificial Intelligence | July 02, 2019
Judy Hung, M.D., director of echocardiography, Division of Cardiology, Massachusetts General Hospital, Boston, discusses how her center is partnering to develop artificial intelligence (AI) applications to help improve image quality and speed workflow in cardiac ultrasound. She spoke to DAIC at the 2019 American Society of Echocardiography (ASE).
Cardiovascular Ultrasound | July 01, 2019
Federico Asch, M.D., FASE, director of cardiac imaging research and director of the cardiovascular imaging lab, MedStar Health Research Institute, Washington, D.C., spoke about the cardiovascular impact of chagas disease and the symptoms that should be considered for patients who are from, or visited, South or Central America. He spoke on the topic at the 2019 American Society Of Echocardiography (ASE) meeting.
Chagas, also called trypanosomiasis, is a tropical parasitic disease caused by the protist Trypanosoma cruzi. It is spread through the bite of the triatominae insect, which is also known as the "kissing bug." Link to the Center for Disease Control (CDC) page on Chagas.
Asch served as the co-chair of the group that created the guidelines to image Chagas disease.
Find more news and video from ASE 2019
Cardiovascular Ultrasound | July 01, 2019
Partho Sengupta, M.D., MBBS, chief of cardiology, West Virginia Heart and Vascular Institute, explains how wearable, smartphone-based apps and medical devices, and artificial intelligence (AI) might be used to cost-effectively triage larger numbers of patients in rural areas and in the developing world for serious diseases. He spoke at the 2019 American Society Of Echocardiography (ASE) meeting.
Sengupta is involved with a pilot program using the Butterfly app and transducer to turn a smartphone into an inexpensive ultrasound system. He said the idea is to have novice ultrasound users screen more patients with these types of devices and the exams either being sent to a remote hospital for reading. He said AI algorithms also could be used to help flag any exams that show abnormalities, which would greatly speed reads and getting these patients treatment.
Watch the related VIDEO: How Smartphones May Revolutionize Healthcare in the Developing World — Interview with Jacques Kpodonu, M.D.,
Find more news and video from ASE 2019
Contrast Media | June 28, 2019
Sharon Mulvagh, M.D., FASE, FACC, FRCPC, professor of medicine, division of cardiology, Dalhousie University, Halifax, Nova Scotia, Canada, and professor emeritus, Mayo Clinic, explains the latest updates to guidelines for the use of cardiovascular ultrasound enhancing imaging agents. She spoke to DAIC at the 2019 American Society of Echocardiography (ASE) meeting.
The changes include a new term for contrast so the agents are not confused with safety issues regarding gadolinium, iodine-based contrast or radioactive nuclear radiotracers. She gives an overview of the 2018 guidelines that are based on a large level of clinical study evidence. Previously, the ASE issued a statement rather than a guideline, because the more clinical evidence was needed for more a more conclusive set of guidelines.
Read the full guidelines: Clinical Applications of Ultrasonic Enhancing Agents in Echocardiography: 2018 American Society of Echocardiography Guidelines Update.
Find more news and videos from ASE 2019.
Artificial Intelligence | June 28, 2019
This is a quick example of how artificial intelligence (AI) is being integrated on the back end of cardiac ultrasound systems to help automate and speed workflows. This video segment is from the expo floor of the 2019 American Society of Echocardiography (ASE) meeting. It shows AI-based AFI automation features incorporated into the GE Vivid E95 echo system.
Read a blog about how AI will help advance cardiac ultrasound imaging, Combatting the No. 1 Cause of Death With the Help of Artificial Intelligence and Advanced Technology.
Cardiac Diagnostics View all 53 items
Cardiovascular Ultrasound | July 01, 2019
Federico Asch, M.D., FASE, director of cardiac imaging research and director of the cardiovascular imaging lab, MedStar Health Research Institute, Washington, D.C., spoke about the cardiovascular impact of chagas disease and the symptoms that should be considered for patients who are from, or visited, South or Central America. He spoke on the topic at the 2019 American Society Of Echocardiography (ASE) meeting.
Chagas, also called trypanosomiasis, is a tropical parasitic disease caused by the protist Trypanosoma cruzi. It is spread through the bite of the triatominae insect, which is also known as the "kissing bug." Link to the Center for Disease Control (CDC) page on Chagas.
Asch served as the co-chair of the group that created the guidelines to image Chagas disease.
Find more news and video from ASE 2019
Cardiovascular Ultrasound | July 01, 2019
Partho Sengupta, M.D., MBBS, chief of cardiology, West Virginia Heart and Vascular Institute, explains how wearable, smartphone-based apps and medical devices, and artificial intelligence (AI) might be used to cost-effectively triage larger numbers of patients in rural areas and in the developing world for serious diseases. He spoke at the 2019 American Society Of Echocardiography (ASE) meeting.
Sengupta is involved with a pilot program using the Butterfly app and transducer to turn a smartphone into an inexpensive ultrasound system. He said the idea is to have novice ultrasound users screen more patients with these types of devices and the exams either being sent to a remote hospital for reading. He said AI algorithms also could be used to help flag any exams that show abnormalities, which would greatly speed reads and getting these patients treatment.
Watch the related VIDEO: How Smartphones May Revolutionize Healthcare in the Developing World — Interview with Jacques Kpodonu, M.D.,
Find more news and video from ASE 2019
Wearables | June 21, 2019
Jacques Kpodonu, M.D., FACC, cardiac surgeon, Beth Israel Deaconess Medical Center, and professor at Harvard Medical School, explains how medical devices and wearables that interface with smartphones and apps might be used to eliminate healthcare disparities in rural areas of the developed world and help raise the level of care in the developing world. He spoke at the 2019 AI-Med Cardiology conference.
Related Smartphone and Wearable Content:
VIDEO: Use of Wearable Medical Devices for Cardiac Rehabilitation — Interview with Robert Klempfner, M.D.
VIDEO: Use of Wearables to Track Electrophysiology Patients — Interview with Khaldoun Tarakji, M.D.
Smartphones Used to Successfully Screen More than 60,000 for Atrial Fibrillation
VIDEO: The Future of Wearables in Healthcare — Interview with Karl Poterack, M.D.
VIDEO: Artificial Intelligence Applications for Cardiology — Interview with Anthony Chang, M.D.
Atrial Fibrillation | June 21, 2019
Sanjaya Gupta, M.D., electrophysiologist, St. Luke's Mid America Heart Institute, and assistant professor, University of Missouri–Kansas City School of Medicine, explains how his center developed an artificial intelligence (AI) application to automatically risk stratify atrial fibrillation (AFib) patients. The Epic-based app stratifies patients into those who should be placed on anticoagulation and those who are candidates for left atrial appendage (LAA) occlusion. He spoke at the 2019 AI-Med Cardiology conference.
His center hopes to develop similar guidelines based AI apps for other types of cardiac risk scoring. Gupta said he is looking for other centers to partner with to co-develop and test these AI apps.
Related Cardiology AI Content:
VIDEO: Overview of Artificial Intelligence and its Use in Cardiology — Interview with Anthony Chang, M.D.
VIDEO: ACC Efforts to Advance Evidence-based Implementation of AI in Cardiovascular Care — Interview with John Rumsfeld, M.D.
VIDEO: Artificial Intelligence Applications for Cardiology — Interview with Anthony Chang, M.D.
PODCAST: Fitting Artificial Intelligence Into Cardiology — Interview with Anthony Chang, M.D.
VIDEO: How Hospitals Should Prepare for Artificial Intelligence Implementation — Interview with Paul Chang, M.D.
Artificial Intelligence | June 20, 2019
John Rumsfeld, M.D., Ph.D., FACC, American College Cardiology (ACC) chief innovation officer, and professor of medicine at the University of Colorado School of Medicine, explains how the ACC is working with artificial intelligence (AI) vendors to directly impact cardiac care. He said there is a tremendous amount of investment in and hype surrounding AI in healthcare, but to date there has been very little of this has translated in to changes in the way cardiology care is delivered. He outlines several areas to successfully apply AI to improve cardiovascular care and outcomes. He also discussed the current ACC efforts to advance evidence-based implementation of AI in cardiac care including applications for the NCDR.
He spoke at the 2019 Cardiology AI-Med conference.
Watch the related VIDEO: Overview of Artificial Intelligence and its Use in Cardiology, an interview with Anthony Chang, M.D., chief artificial intelligence officer, Children’s Hospital of Orange County (CHOC), and founder of AIMed.
Cardiac Diagnostics | March 26, 2019
Kim Allan Williams, Sr., M.D., chief of the Division of Cardiology and the James B. Herrick Professor at Rush University Medical Center, , and former American College of cardiology (ACC) president, discusses the importance of a plant-based diet to improve cardiovascular health and why he went vegan.
Other Interviews With Dr. Williams:
VIDEO: Reducing Hypertension Among African-Americans
VIDEO: Imaging in the Assessment of Preventive Cardiology
Wearables | March 26, 2019
Khaldoun Tarakji, M.D., MPH, staff physician in the Section of Electrophysiology and Pacing in the Robert and Suzanne Tomsich Department of Cardiovascular Medicine, Sydell and Arnold Miller Family Heart and Vascular Institute at the Cleveland Clinic, explains how wearable devices and smart phone apps can be used to aid electrophysiologists in patient care. He said the devices offer a constant remote monitoring of patient heart data, which can be helpful in diagnosing various types of arrhythmias and cardiac conditions. However, the main issue is how to sort through the large volumes of data and to figure out what the clinical value of some of this consumer data is through studies. He spoke at the American College of Cardiology (ACC) 2019 meeting.
Other Cardiac Wearable Content:
VIDEO: Use of Wearable Medical Devices for Cardiac Rehabilitation — Interview with Robert Klempfner, M.D.
VIDEO: The Future of Wearables in Healthcare — Interview with Karl Poterack, M.D.
Wearables | March 08, 2019
Karl Poterack, M.D., medical director, applied clinical informatics, Mayo Clinic, explains the role wearable devices will play in healthcare. He presented in several sessions at the 2019 Healthcare Information Management and Systems Society at (HIMSS) conference.
Poterack said there is a brewing tsunami of data in wearable technologies that healthcare systems will have to figure out how to integrate in the coming years. He said the key issue with wearable data is that there needs to be outcomes data showing the value of how many steps a patient accumulates, changes in heart rate over time, or blood pressure changes in patients with specific aliments. Without this , he said there is limited value in the information.
Watch the related VIDEO: Use of Wearable Medical Devices for Cardiac Rehabilitation.
Look through a photo gallery of other new technologies at HIMSS19.
EP Lab View all 56 items
Atrial Fibrillation | June 21, 2019
Sanjaya Gupta, M.D., electrophysiologist, St. Luke's Mid America Heart Institute, and assistant professor, University of Missouri–Kansas City School of Medicine, explains how his center developed an artificial intelligence (AI) application to automatically risk stratify atrial fibrillation (AFib) patients. The Epic-based app stratifies patients into those who should be placed on anticoagulation and those who are candidates for left atrial appendage (LAA) occlusion. He spoke at the 2019 AI-Med Cardiology conference.
His center hopes to develop similar guidelines based AI apps for other types of cardiac risk scoring. Gupta said he is looking for other centers to partner with to co-develop and test these AI apps.
Related Cardiology AI Content:
VIDEO: Overview of Artificial Intelligence and its Use in Cardiology — Interview with Anthony Chang, M.D.
VIDEO: ACC Efforts to Advance Evidence-based Implementation of AI in Cardiovascular Care — Interview with John Rumsfeld, M.D.
VIDEO: Artificial Intelligence Applications for Cardiology — Interview with Anthony Chang, M.D.
PODCAST: Fitting Artificial Intelligence Into Cardiology — Interview with Anthony Chang, M.D.
VIDEO: How Hospitals Should Prepare for Artificial Intelligence Implementation — Interview with Paul Chang, M.D.
Left Atrial Appendage (LAA) Occluders | April 25, 2019
This video offers an overview of the Watchman left atrial appendage (LAA) occluder system, including information of its design, implantation and clinical data supporting its use. Catheter-based LAA occlusion is used to seal off the LAA in the heart, which is the source of most stroke-causing clots in patients with atrial fibrillation (Afib). The device be used in place of anticoagulation therapy for stroke prevention.
Related LAA Occlusion Content:
VIDEO: New Data on LAA Occlusion From the PREVAIL and PROTECT Trials — Interview with Vivek Reddy, M.D.
Occluding the Left Atrial Appendage (LAA)
VIDEO: Comparison Between Watchman vs. Amulet LAA Occluders — Interview with Ashish Pershad, M.D.
Device-related Thrombus After Watchman LAA Closure Occurs in Small Number of Patients
Closure of Left Atrial Appendage During Heart Surgery Protects the Brain
March 28, 2019
Interview with Frederick Masoudi, M.D., FACC, FAHA, professor of cardiology at the University of Colorado Hospital, and a physician leader of the National Cardiovascular Data Registry (NCDR). The NCDR is the American College of Cardiology's suite of cardiovascular data registries helping hospitals and private practices measure and improve the quality of care they provide.
Additional videos and coverage of the University of Colorado Hospital
Wearables | March 26, 2019
Khaldoun Tarakji, M.D., MPH, staff physician in the Section of Electrophysiology and Pacing in the Robert and Suzanne Tomsich Department of Cardiovascular Medicine, Sydell and Arnold Miller Family Heart and Vascular Institute at the Cleveland Clinic, explains how wearable devices and smart phone apps can be used to aid electrophysiologists in patient care. He said the devices offer a constant remote monitoring of patient heart data, which can be helpful in diagnosing various types of arrhythmias and cardiac conditions. However, the main issue is how to sort through the large volumes of data and to figure out what the clinical value of some of this consumer data is through studies. He spoke at the American College of Cardiology (ACC) 2019 meeting.
Other Cardiac Wearable Content:
VIDEO: Use of Wearable Medical Devices for Cardiac Rehabilitation — Interview with Robert Klempfner, M.D.
VIDEO: The Future of Wearables in Healthcare — Interview with Karl Poterack, M.D.
EP Lab | March 21, 2019
Khaldoun Tarakji, M.D., MPH, associate section head, section of electrophysiology and pacing in the Robert and Suzanne Tomsich Department of Cardiovascular Medicine, Sydell and Arnold Miller Family Heart and Vascular Institute at the Cleveland Clinic. He presented the WRAP-IT late-breaking trial at the American College of Cardiology (ACC) 2019 meeting. The trial looked at the use of an antibacterial envelope for pacemakers and ICDs to reduce infection risk.
Read the ACC.19 article Medtronic Tyrx Envelope Significantly Reduces Major Infections in Cardiac Implantable Device Patients.
Rlated EP video From ACC.19:
VIDEO: Key Trends in Electrophysiology — Apple Watch to Detect AF and the CABANA Trial — Interview with Christine Albert, M.D.
Atrial Fibrillation | March 21, 2019
Christine Albert, M.D., MPH, director of the Center for Arrhythmia Prevention at Brigham and Women’s Hospital, and professor of medicine at Harvard Medical School, spoke at the American College of Cardiology (ACC) 2019 meeting, and also with ITN/DAIC Contributing Editor Greg Freiherr. In her interview, she focused on two key electrophysiology trends with the use of the Apple Watch to detect atrial fibrillation (AF) and the results of the CABANA Trial, which showed ablation is as effective as drug therapy in treating AF, with a significant reduction in death or cardiovascular hospitalization.
Related EP Trend Content:
Heart Rhythm 2018 Late-breaking Studies
VIDEO: Advances in Electrophysiology Technology — Interview with Michael Gold, M.D.
VIDEO: Use of a Virtual Heart For CRT Lead Placement Optimization
New Atrial Fibrillation Guidelines Recommend NOACs Over Warfarin
Use of the Interventional CRT Approach to Solve Issues With LV Lead Placement
Novel Antibiotics Can Help Lower EP Device Infection Rates
New Approaches to EP Lead Management
VIDEO: Cryoballoon Ablation Best Practice Guidelines — Interview with Wilber Su, M.D.
EP Lab | February 27, 2019
This is a virtual heart with the same electrophysiology characteristics as the real patient being developed to help optimize cardiac resynchronization therapy (CRT) lead placement. CRT currently has a 30 percent nonresponder rate, which is mainly due to the placement of leads. This model allows virtual placement of the leads In various locations to test response prior to the implantation procedure. The green dot shows the location of the virtual lead. It was unveiled at the Healthcare Information Management and Systems Society (HIMSS) 2019 annual meeting in February by Siemens. This "digital twin" technology is in development and will be able to create virtual, digital organs from a patient’s ECG, MRI scan and other clinical data. Siemens said the technology also might have applications for testing virtual ablations strategies to save procedure time when the patient is in the EP lab.
Read more about the digital twin technology.
Look through a photo gallery of other new technologies at HIMSS19.
Find news and videos from HIMSS 2019.
EP Lab | January 03, 2019
This is a quick video tour of one of the dedicated electrophysiology (EP) labs at the University of Colorado Hospital. The room is built around a Siemens Artis Q.zen bi-plane angiography system. The system allows low radiation fluoro imaging, which reduced exposure to both patients and operators during long EP ablation procedures.
Equipment in stock in this lab includes the Medtronic Artic Front cryoablation balloon.
Watch the VIDEO: Cryoballoon Ablation Best Practice Guidelines, an interview with Wilber Su, M.D.
Watch the related VIDEO: Cath Lab Walk Through at the University of Colorado Hospital
Find more articles and videos on the University of Colorado Hospital
Information Technology View all 135 items
Cardiovascular Ultrasound | July 10, 2019
This is an example of a cardiac echocardiography exam performed using an iPhone and the Butterfly IQ ultrasound transducer and app. The company is exhibiting at the American Society Of Echocardiography (ASE) 2019 meeting. This is the first “ultrasound system on a chip.” The Butterfly IQ ultrasound system consists of a transducer that connects to an iPhone or iPad to record ultrasound exams. The system has 18 different applications for specialized images, including cardiac imaging, vascular, lung, abdominal and others. The apps allow for quantification and offers many of the features of larger cart-based systems. The company is working on incorporating artificial intelligence technologies to automate some processes, such as auto ejection fractions.
This technology was picked as one of the big ultrasound advances in the VIDEO: 4 Recent Advances in Echocardiography Technology and in the VIDEO: Editor's Choice of the Most Innovative New Technology at RSNA 2018.
Artificial Intelligence | July 02, 2019
Judy Hung, M.D., director of echocardiography, Division of Cardiology, Massachusetts General Hospital, Boston, discusses how her center is partnering to develop artificial intelligence (AI) applications to help improve image quality and speed workflow in cardiac ultrasound. She spoke to DAIC at the 2019 American Society of Echocardiography (ASE).
Cardiovascular Ultrasound | July 01, 2019
Partho Sengupta, M.D., MBBS, chief of cardiology, West Virginia Heart and Vascular Institute, explains how wearable, smartphone-based apps and medical devices, and artificial intelligence (AI) might be used to cost-effectively triage larger numbers of patients in rural areas and in the developing world for serious diseases. He spoke at the 2019 American Society Of Echocardiography (ASE) meeting.
Sengupta is involved with a pilot program using the Butterfly app and transducer to turn a smartphone into an inexpensive ultrasound system. He said the idea is to have novice ultrasound users screen more patients with these types of devices and the exams either being sent to a remote hospital for reading. He said AI algorithms also could be used to help flag any exams that show abnormalities, which would greatly speed reads and getting these patients treatment.
Watch the related VIDEO: How Smartphones May Revolutionize Healthcare in the Developing World — Interview with Jacques Kpodonu, M.D.,
Find more news and video from ASE 2019
Artificial Intelligence | June 28, 2019
This is a quick example of how artificial intelligence (AI) is being integrated on the back end of cardiac ultrasound systems to help automate and speed workflows. This video segment is from the expo floor of the 2019 American Society of Echocardiography (ASE) meeting. It shows AI-based AFI automation features incorporated into the GE Vivid E95 echo system.
Read a blog about how AI will help advance cardiac ultrasound imaging, Combatting the No. 1 Cause of Death With the Help of Artificial Intelligence and Advanced Technology.
Cardiovascular Ultrasound | June 28, 2019
Marielle Scherrer-Crosbie, M.D., Ph.D., director of echocardiography at the Hospital of the University of Pennsylvania, and chair of the 2019 American Society Of Echocardiography (ASE) sessions, explains how cardiac ultrasound strain imaging is being used and where the technology is at the ASE 2019 meeting. She is an expert in echo strain, which is gaining wider usage in echocardiography, especially for cardio-oncology assessments. She spoke at the 2019 American Society of Echocardiography (ASE) meeting.
Related Cardio-oncology Content:
VIDEO: Echocardiography Strain Fundamentals Made Easy
Strain Imaging Improves Cardiac Surveillance of Certain Breast Cancer Patients
Assessing Cardiotoxicity Due to Cancer Therapy
VIDEO: Assessing Cardiotoxicity Response With Cardio-Oncology Echo Imaging — interview with Federico Asch, M.D.
New Echo Protocol Aids Monitoring Children’s Heart Abnormalities Due to Chemotherapy
Strain Imaging Improves Cardiac Surveillance of Certain Breast Cancer Patients
VIDEO: Characterization of Cardiac Structural Changes and Function Following Radiation Therapy
Study Demonstrates Strain Imaging Utility With Contrast-Echo Studies
VIDEO: Echocardiography Strain Fundamentals Made Easy
Strain Imaging Improves Cardiac Surveillance of Certain Breast Cancer Patients
Automation Enhances, Streamlines Echocardiography
Virtual and Augmented Reality | June 27, 2019
Roberto Lang, M.D., director of cardiac imaging at the University of Chicago, has been working with TomTec for the past three years on a project to use virtual reality (VR) to edit and view 3-D cardiac ultrasound and CT scans. He spoke at a couple sessions this week at the 2019 American Society Of Echocardiography (ASE) meeting, where doctors were able to view the session using VR headsets. The hands-on demonstration of this technology in the TomTec booth at ASE 2018 and 2019 was one of the most popular exhibits with attendees both years.
Read more about this technology in Top Technology Trends in Echocardiography at ASE 2018
See examples of VR technology for echo in the VIDEO: Editor’s Choice of the Most Innovative Echo Technology at ASE 2018
Here is a video example of this technology being demonstrated at ASE19.
Wearables | June 21, 2019
Jacques Kpodonu, M.D., FACC, cardiac surgeon, Beth Israel Deaconess Medical Center, and professor at Harvard Medical School, explains how medical devices and wearables that interface with smartphones and apps might be used to eliminate healthcare disparities in rural areas of the developed world and help raise the level of care in the developing world. He spoke at the 2019 AI-Med Cardiology conference.
Related Smartphone and Wearable Content:
VIDEO: Use of Wearable Medical Devices for Cardiac Rehabilitation — Interview with Robert Klempfner, M.D.
VIDEO: Use of Wearables to Track Electrophysiology Patients — Interview with Khaldoun Tarakji, M.D.
Smartphones Used to Successfully Screen More than 60,000 for Atrial Fibrillation
VIDEO: The Future of Wearables in Healthcare — Interview with Karl Poterack, M.D.
VIDEO: Artificial Intelligence Applications for Cardiology — Interview with Anthony Chang, M.D.
Atrial Fibrillation | June 21, 2019
Sanjaya Gupta, M.D., electrophysiologist, St. Luke's Mid America Heart Institute, and assistant professor, University of Missouri–Kansas City School of Medicine, explains how his center developed an artificial intelligence (AI) application to automatically risk stratify atrial fibrillation (AFib) patients. The Epic-based app stratifies patients into those who should be placed on anticoagulation and those who are candidates for left atrial appendage (LAA) occlusion. He spoke at the 2019 AI-Med Cardiology conference.
His center hopes to develop similar guidelines based AI apps for other types of cardiac risk scoring. Gupta said he is looking for other centers to partner with to co-develop and test these AI apps.
Related Cardiology AI Content:
VIDEO: Overview of Artificial Intelligence and its Use in Cardiology — Interview with Anthony Chang, M.D.
VIDEO: ACC Efforts to Advance Evidence-based Implementation of AI in Cardiovascular Care — Interview with John Rumsfeld, M.D.
VIDEO: Artificial Intelligence Applications for Cardiology — Interview with Anthony Chang, M.D.
PODCAST: Fitting Artificial Intelligence Into Cardiology — Interview with Anthony Chang, M.D.
VIDEO: How Hospitals Should Prepare for Artificial Intelligence Implementation — Interview with Paul Chang, M.D.
